One Size Doesn't Fit All. Especially When It Comes to Cancer.
What if cancer treatment could be designed around the unique characteristics of your cancer? Discover how precision medicine is changing care and why knowing your options matters.
Imagine two people walking into a doctor's office with the exact same cancer diagnosis.
Same type of cancer. Similar stage. Maybe even similar ages.
But they walk out with two completely different treatment plans.
Why?
Because scientists are discovering that what makes one person's cancer grow may be very different from what drives another person's cancer, even when those cancers start in the same part of the body.
And that discovery is helping transform cancer care.
Welcome to the world of precision medicine, where understanding the individual characteristics of a person's cancer can help doctors make more informed treatment decisions.
What Exactly Is Precision Medicine?
For years, cancer treatment has largely been guided by where a cancer begins, how large it is, and whether it has spread.
Those factors are still essential. But now scientists can sometimes look deeper, examining the genes, proteins, and other molecular characteristics that help a cancer grow.
This approach is called precision medicine, sometimes referred to as personalized medicine.
Think of it this way.
Traditional cancer care helps doctors understand what type of cancer they're treating.
Precision medicine can provide additional information about what's happening inside that cancer and which treatments may be more likely to work.
It's not necessarily about developing a completely different drug for every person.
It's about using detailed biological information to make more precise decisions about care.
Your Cancer Has Its Own Biological Fingerprint
Here's where the science gets fascinating.
Cancer cells can contain genetic changes that aren't present in healthy cells.
Some of those changes help cancer cells grow, divide, and survive.
Others may make cancer cells vulnerable to specific treatments.
Scientists can look for these characteristics through biomarker testing, which examines certain genes, proteins, or other features of cancer cells.
For example:
Breast cancer: Testing for HER2 and hormone receptors can help determine whether particular targeted or hormone-based treatments may be effective.
Lung cancer: Certain changes in genes such as EGFR or ALK can help identify people who may benefit from specific targeted drugs.
Colorectal cancer: Testing for markers such as KRAS or mismatch repair status can help guide targeted therapy or immunotherapy decisions.
The science behind these treatments can be complicated, but the idea is simple:
The more doctors understand about a cancer's biology, the better equipped they may be to identify appropriate treatment options.
It's Not Just About Chemotherapy Anymore
Chemotherapy remains an essential and effective treatment for many cancers.
But precision medicine has helped expand the options available for some patients.
One important advance is targeted therapy.
Instead of broadly attacking rapidly dividing cells, targeted drugs act on particular molecules or signals involved in cancer growth.
Another advance involves immunotherapy, which helps the immune system recognize or attack cancer. Certain biomarkers can help predict whether specific immunotherapies are more likely to work.
For some patients, these approaches can produce remarkable results.
But they aren't magic bullets.
Not every cancer has an identifiable treatment target. A targeted medication may stop working if cancer cells develop resistance. And these therapies can still cause serious side effects.
Precision medicine isn't about guaranteeing a cure.
It's about using science to make more informed choices.
Could the Same Drug Treat Different Types of Cancer?
Here's something that might surprise you.
Some cancer treatments are now approved based on specific molecular features of a tumor, rather than only where the cancer began.
This is sometimes called tumor-agnostic treatment.
Imagine a person with colorectal cancer and another with a completely different cancer type.
If both tumors have a particular biomarker, they may qualify for the same targeted treatment, depending on the drug's approved indications and other clinical factors.
That's a major shift in how we think about cancer.
Instead of asking only, "Where did the cancer start?" researchers are increasingly asking, "What is driving this cancer, and can we target it?"
Precision Medicine Goes Beyond Treating a Tumor
The concept also extends to prevention, risk assessment, and medication safety.
Inherited genetic testing can identify some people who may benefit from earlier screening or additional preventive strategies.
Pharmacogenomic testing examines how a person's inherited genes may affect their response to certain medications. In some situations, it can help doctors select a safer dose or avoid medications associated with increased side-effect risks.
And researchers continue exploring ways to detect cancer earlier and monitor treatment more accurately using molecular information.
These advances are at different stages of development, and not every approach is ready for routine clinical use.
But together, they point toward a future in which cancer care becomes more informed by the biology of both the person and the disease.
There's a Catch: Not Everyone Has Equal Access
As exciting as precision medicine is, there's a challenge we can't ignore.
Access.
Advanced testing and targeted treatments aren't available at every healthcare facility. Insurance coverage varies. Some patients face long travel distances, high costs, or limited access to specialists who can interpret complex test results.
Clinical research also needs to reflect the wide range of people who will ultimately receive these treatments.
Scientific breakthroughs only reach their full potential when people can actually benefit from them.
Expanding access to testing, improving affordability, and making precision medicine available across more communities are essential parts of improving cancer outcomes.
Is Precision Medicine Right for Everyone?
Not necessarily.
Some cancers already have well-established biomarker testing and treatment options. Others have fewer clinically useful molecular targets.
And even when testing identifies a genetic change, there may not be an available treatment that addresses it.
Sometimes the most effective care remains surgery, radiation, chemotherapy, or a combination of established approaches.
Precision medicine doesn't replace these treatments. It may help doctors determine when specific treatments should be added, avoided, or selected.
Five Questions to Ask Your Healthcare Team
If you or someone you love has been diagnosed with cancer, these questions can help start a conversation:
Could precision medicine play a role in treating my cancer?
Has my tumor been tested for biomarkers that could guide treatment?
Are targeted therapies or immunotherapies appropriate for my diagnosis?
Are there clinical trials based on my cancer's molecular characteristics?
Would additional genetic or molecular testing change my treatment options?
You don't need to understand every gene, protein, or scientific term to participate in decisions about your care.
You just need the opportunity to ask questions and understand the answers.
The Bottom Line: Cancer Care Is Becoming More Personal
For generations, cancer treatment has advanced through discoveries that help more people live longer and better lives.
Precision medicine represents another important step forward.
It's helping doctors recognize that two people with the same diagnosis may have cancers that behave differently and respond to different treatments.
There is still much to learn. Precision medicine won't benefit every patient in the same way, and it isn't a guarantee of better outcomes.
But it is giving researchers and healthcare professionals new ways to understand cancer and, in some circumstances, identify more effective treatment strategies.
Because when it comes to cancer, knowing the diagnosis is important. Understanding the biology behind it could change the conversation.
Take the Next Step
Ask About Precision Medicine
If you or someone you love is navigating a cancer diagnosis, ask whether biomarker testing, targeted therapy, or other precision medicine approaches may be appropriate.
Explore Touch4Life's Biomarker Toolkit to better understand the science and prepare for informed conversations with your healthcare team.
Sources & Further Reading
Medical Disclaimer: This article is intended for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional about your cancer diagnosis, genetic testing, and treatment options.
Comments